UNH
UnitedHealth Group Incorporated
NYSE · Healthcare · Medical - Healthcare Plans · US
$397.14
−0.95%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 450.1B | 447.6B | 400.3B | 371.6B | 324.2B |
| Cost of Revenue | 348.9B | 364.6B | 310.9B | 280.7B | 244.5B |
| Gross Profit | 101.2B | 82.9B | 89.4B | 91.0B | 79.6B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 15.4B | — | — | — | — |
| General & Admin Expense | 15.4B | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 64.1B | 64.0B | 57.1B | 58.6B | 51.2B |
| Total Operating Expenses | 79.5B | 64.0B | 57.1B | 58.6B | 51.2B |
| Cost and Expenses | 428.5B | 428.6B | 368.0B | 339.3B | 295.7B |
| Operating Income (EBIT) | 21.7B | 19.0B | 32.3B | 32.4B | 28.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 3.9B | 4.0B | 3.9B | 3.2B | 2.1B |
| Net Interest Income | (3.9B) | (4.0B) | (3.9B) | (3.2B) | (2.1B) |
| Other Non-Op Income/Expense | (4.2B) | (4.3B) | (12.2B) | (3.2B) | (2.1B) |
| Non-Operating Income (excl Interest) | 198.0M | 265.0M | 8.3B | — | — |
| EBT (Pre-Tax Income) | 17.4B | 14.7B | 20.1B | 29.1B | 26.3B |
| Income Tax Expense | 2.5B | 1.9B | 4.8B | 6.0B | 5.7B |
| Bottom Line | |||||
| Net Income | 14.1B | 12.1B | 14.4B | 22.4B | 20.1B |
| Earnings from Cont. Ops | 14.9B | 12.8B | 15.2B | 23.1B | 20.6B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 14.1B | 12.1B | 14.4B | 22.4B | 20.1B |
| Per Share | |||||
| Basic EPS | $15.55 | $13.23 | $15.64 | $24.12 | $21.54 |
| Diluted EPS | $15.55 | $13.23 | $15.51 | $23.86 | $21.18 |
| Revenue Per Share | $496.83 | $491.83 | $430.87 | $400.45 | $347.07 |
| Shares | |||||
| Basic Shares Outstanding | 906.0M | 910.0M | 929.0M | 928.0M | 934.0M |
| Diluted Shares Outstanding | 906.0M | 910.0M | 929.0M | 938.0M | 950.0M |
| Profitability Metrics | |||||
| EBITDA | 25.8B | 23.1B | 28.1B | 36.3B | 31.8B |
| D&A | 4.3B | 4.4B | 4.1B | 4.0B | 3.4B |
| EBIT | 21.5B | 18.7B | 24.0B | 32.4B | 28.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026